John R. Copeland

About

Lead a global team that identifies, evaluates and executes transactions across all markets outside of the US. We find collaborations that focus on improving access to health innovation, optimising operational efficiencies and identifying innovative assets in the biotech sector.

Experience

• Corporate Development Leader - Japan, China, Asia Pacific, Europe, Middle East, Africa at MSD
  Jul 2020 - Present · 6 yrs

• Merck (26 yrs 4 mos)
  • AVP Corporate Development Japan, China & Asia Pacific
    Mar 2018 - Jul 2020 · 2 yrs 5 mos

    Lead corporate transactions and partnerships across all Asia markets for MSD

  • Global Franchise Leader - Merck Alzheimer's Disease - verubecestat MK-8931
    Feb 2016 - Mar 2018 · 2 yrs 2 mos

    Lead transition of MK-8931 (verubecestat) from development into commercialization and launch planning across key global markets. Drive commercial input and efforts across medical, regulatory, finance, supply decisions. Lead engagement with Regional & Country leadership to evolve market understanding and preparation in the Alzheimer's disease space. Maintain responsibilities for neuroscience development portfolio across Alzheimer's, Parkinson's, Schizophrenia and Psychosis

  • Global Commercial Operations Leader - Hospital & Specialty Business Unit
    Apr 2013 - Mar 2018 · 5 yrs

    Commercial Operations lead for Global Hospital & Specialty business unit. Lead global business unit strategic plan development and implementation.Business Operations lead for supply chain optimization, inventory management, headcount / expense management, budgeting and annual planning. Business unit covers Neurology, Immunology, HIV, HCV, Acute Care Hospital.

• National Account Sales at Bell South
  Feb 1993 - Apr 1994 · 1 yr 3 mos

• Legislative Aide at United States House of Representatives
  Jan 1991 - Jan 1993 · 2 yrs 1 mo